A phase II trial of risk-enabled therapy after initiating neoadjuvant chemotherapy for bladder cancer (RETAIN)
Geynisman, Daniel M. ; Abbosh, Philip ; Ross, Eric A. ; Zibelman, Matthew R. ; Ghatalia, Pooja ; Anari, Fern ; Ansel, Katherine ; Mark, James Ryan ; Stamatakis, Lambros ; Hoffman-Censits, Jean H. ; Viterbo, Rosalia ; Horwitz, Eric M. ; Hallman, Mark A ; Alpaugh, R. Katherine ; Greenberg, Richard E. ; Smaldone, Marc C. ; Uzzo, Robert ; Chen, David ; Kutikov, Alexander ; Plimack, Elizabeth R.
Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.438-438 [Periódico revisado por pares]Texto completo disponível